Prospect News: News for Dechra Pharmaceuticals plc

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

User:

Log out

Prospect News home > Main news index > All issuers starting with D > All stories on Dechra Pharmaceuticals plc

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Dechra Pharmaceuticals plc

12/4/2024	BK	Dechra Pharmaceuticals firms €800 million term loan B at 99.75 OID
12/3/2024	BK	Market Commentary: Dechra breaks; Veritiv, Quickbase, Cimpress, Morton, Crisis Prevention and more set talk
12/3/2024	CLHY	Market Commentary: Dechra breaks; Veritiv, Quickbase, Cimpress, Morton, Crisis Prevention and more set talk
12/3/2024	BK	Dechra finalizes sizes on U.S. and euro term loans, updates pricing
12/2/2024	CLHY	Market Commentary: Dechra updated; Culligan, Vistra, BrightSpring, CQP, Innio, Starwood and many more set talk
12/2/2024	BK	Market Commentary: Dechra updated; Culligan, Vistra, BrightSpring, CQP, Innio, Starwood and many more set talk
12/2/2024	BK	Dechra changes talk on Ł1.3 billion equivalent U.S, euro term loan
11/27/2024	BK	Market Commentary: Dechra Pharmaceuticals, Exclusive Networks, StepStone Group deadlines approaching
11/27/2024	CLHY	Market Commentary: Dechra Pharmaceuticals, Exclusive Networks, StepStone Group deadlines approaching
11/25/2024	BK	Market Commentary: Rocket Software, Resideo, Buyers Edge, Wood Mackenzie free to trade; Dechra accelerated
11/25/2024	CLHY	Market Commentary: Rocket Software, Resideo, Buyers Edge, Wood Mackenzie free to trade; Dechra accelerated
11/21/2024	BK	Market Commentary: Westinghouse, Sophos, RelaDyne, IntraFi, Evertec, Minerals, Dotdash, Cloud and more break
11/21/2024	BK	Dechra sets talk on Ł1.3 billion equivalent U.S, euro term loan
11/20/2024	BK	Market Commentary: Caesars, LifePoint break; Cloud, American Auto, Socotec revised; Evertec accelerated
11/20/2024	CLHY	Market Commentary: Caesars, LifePoint break; Cloud, American Auto, Socotec revised; Evertec accelerated
11/20/2024	BK	Dechra to launch Ł1.3 billion equivalent U.S, euro term loan Thursday
6/2/2023	BK	EQT Funds and Luxinva will acquire Dechra with equity and debt
7/14/2022	PV	New Issue: Dechra issues €150 million of notes in two parts via private placement
1/6/2020	BK	Dechra to use facility borrowings to finance Osurnia acquisitions
12/18/2019	PV	New Issue: Dechra issues €50 million, $100 million notes via two-part placement

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.